ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesF13.159

F13.159

Billable

Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 F13.159 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified.

Key Diagnostic Point:

F13.159 refers to a condition characterized by the abuse of sedative, hypnotic, or anxiolytic substances, leading to a psychotic disorder induced by these substances. This diagnosis is applicable when the individual exhibits symptoms of psychosis, such as hallucinations, delusions, or disorganized thinking, as a direct result of the misuse of these medications. Sedatives, hypnotics, and anxiolytics include a variety of medications, such as benzodiazepines and barbiturates, which are often prescribed for anxiety, insomnia, or other related disorders. The abuse of these substances can lead to significant impairment in social, occupational, or other important areas of functioning. The unspecified nature of the psychotic disorder indicates that the specific type of psychotic disorder is not clearly defined or documented. Treatment typically involves a combination of detoxification, psychotherapy, and possibly pharmacotherapy to manage withdrawal symptoms and address underlying mental health issues.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiating between substance-induced and primary psychotic disorders
  • Documenting the severity and duration of substance use
  • Identifying co-occurring mental health disorders
  • Understanding the nuances of substance withdrawal symptoms

Audit Risk Factors

  • Inadequate documentation of substance use history
  • Failure to specify the type of psychotic disorder
  • Lack of evidence for treatment plans and follow-up
  • Misclassification of substance-induced symptoms as primary disorders

Specialty Focus

Medical Specialties

Psychiatry

Documentation Requirements

Comprehensive assessment of mental health history, substance use history, and current symptoms.

Common Clinical Scenarios

Patients presenting with acute psychosis following sedative use, or those with a history of substance abuse seeking psychiatric evaluation.

Billing Considerations

Careful differentiation between primary psychotic disorders and those induced by substance use is crucial for accurate coding.

Addiction Medicine

Documentation Requirements

Detailed documentation of substance use patterns, withdrawal symptoms, and treatment interventions.

Common Clinical Scenarios

Patients undergoing detoxification from sedatives or those in rehabilitation programs experiencing psychotic symptoms.

Billing Considerations

Understanding the interplay between addiction and mental health is essential for effective treatment and coding.

Coding Guidelines

Inclusion Criteria

Use F13.159 When
  • According to ICD
  • 10 guidelines, this code should be used when there is clear evidence of substance abuse leading to a psychotic disorder
  • Documentation must support the diagnosis, including details of substance use, symptoms, and treatment

Exclusion Criteria

Do NOT use F13.159 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

99214CPT Code

Established patient office visit, level 4

Clinical Scenario

Used for follow-up visits for patients with substance use disorders and associated psychotic symptoms.

Documentation Requirements

Document the patient's history, mental status examination, and treatment plan.

Specialty Considerations

Psychiatrists and addiction specialists should ensure comprehensive documentation to support the complexity of care.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of substance use disorders, improving the ability to capture the nuances of conditions like F13.159. This specificity aids in better treatment planning and resource allocation.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of substance use disorders, improving the ability to capture the nuances of conditions like F13.159. This specificity aids in better treatment planning and resource allocation.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of substance use disorders, improving the ability to capture the nuances of conditions like F13.159. This specificity aids in better treatment planning and resource allocation.

Resources

Clinical References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Coding & Billing References

  • •
    Substance Abuse and Mental Health Services Administration (SAMHSA)

Frequently Asked Questions

What is the difference between F13.159 and F13.10?

F13.159 includes the presence of a psychotic disorder induced by sedative, hypnotic, or anxiolytic abuse, while F13.10 refers to dependence without psychotic symptoms.